Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal-Reference-Cited by-同舟云学术

Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal

Published:2011-12 Issue:49 Volume:286 Page:42292-42302
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lu Yuanzhi,Roy Satavisha,Nuovo Gerard,Ramaswamy Bhuvaneswari,Miller Tyler,Shapiro Charles,Jacob Samson T.,Majumder Sarmila

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

2. Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

3. Tamoxifen for early breast cancer: an overview of the randomised trials

4. Mechanisms of Endocrine Resistance in Breast Cancer

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary study on miRNA in prostate cancer;World Journal of Surgical Oncology;2023-08-29

2. Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer;2023-06-10

3. Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis;Cancers;2022-09-16

4. The regulatory role of pivotal microRNAs in the AKT signaling pathway in breast cancer;Current Molecular Medicine;2021-07-08

5. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention;Seminars in Cancer Biology;2021-07